FindTrial
Sign In

Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease

Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease - Effect of drugs associated with gastric acid on concentration of levodopa preparations in Parkinson's disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036494
Enrollment
30
Registered
2019-05-01
Start date
2019-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Discontinuance of taking medicine affecting gastric acid for 14 days

Sponsors

Saiseikai Matsuyama Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease who take medicine affecting gastric pH

Exclusion criteria

Exclusion criteria: 1. Patients with a history of gastrointestinal ulcers 2. Patients judged inappropriate with other reasons by investigators

Design outcomes

Primary

MeasureTime frame
Concentration of levodopa preparations—

Countries

Japan

Contacts

Public ContactNoriyuki MIyaue

Saiseikai Matsuyama Hospital Department of Neurology

miyaue@m.ehime-u.ac.jp089-951-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026